search icon

      Market Snapshot

      blog search icon

      NMTR Stock Price History and Quote Analysis: Insights for Investors

      9 Meters Biopharma, Inc.

      (NASDAQ:NMTR)

      $0.66

      -0.15 (-18.54%)

      At Close: 4:00 PM

      $0.81

      0.00 (0.00%)

      Pre Market: 7:19 AM

      NMTR Stock Price Graph

      • 1D
      • 5D
      • 1M
      • 3M
      • 6M
      • 1Y
      • YTD
      • All

      NMTR Stock Price Today

      9 Meters Biopharma, Inc. (NMTR) stock declined over -18.54% intraday to trade at $0.6598 a share on NASDAQ. The stock opened with a loss of -1.23% at $0.80 and touched an intraday high of $0.80, falling -18.54% against the last close of $0.81. The 9 Meters Biopharma, Inc. in stock market went to a low of $0.75 during the session.

      NMTR Stock Snapshot

      $0.81

      Prev. Close

      10 Million

      Market Cap

      $0.75

      Day Low

      $0.80

      Open

      13 Million

      Number of Shares

      $0.80

      Day High

      N/A

      P/E ratio

      -3.38

      EPS (TTM)

      0.48

      Cash Flow per Share

      3.78

      Free Float in %

      -0.44

      Book Value

      355314.00

      Volume

      NMTR Stock Price History Chart

      DateOpenHighLowCloseVolume
      2023-02-14$2.16$2.24$2.09$2.1429496.00
      2023-02-13$2.29$2.29$2.14$2.1676300.00
      2023-02-10$2.37$2.43$2.25$2.3264000.00
      2023-02-08$2.56$2.63$2.45$2.5263342.00
      2023-02-07$2.61$2.61$2.35$2.58123000.00
      2023-02-06$2.35$2.62$2.26$2.61117600.00
      2023-02-03$2.29$2.37$2.24$2.3190677.00
      2023-02-02$2.24$2.34$2.10$2.33119800.00
      2023-02-01$2.02$2.25$2.00$2.16101100.00
      2023-01-31$2.00$2.09$1.96$2.0254600.00

      Contact Details

      8480 Honeycutt Road
      Raleigh, NC 27615
      US

      Website:https://www.9meters.com

      Contact #:919 275 1933

      Company Information

      Employees10.00

      Beta1.36

      Sales or RevenueN/A

      5Y Sales ChangeN/A

      Fiscal Year EndsDec. 2022

      SectorHealthcare

      IndustryBiotechnology

      About Company

      9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as well as in Phase IIa clinical trial for treatment of multi-system inflammatory syndrome; and Vurolenatide, a long-acting injectable glucagon-like-peptide-1 that is in Phase 2 clinical trial to treat short bowel syndrome. It also develops NM-102, a small molecule peptide; NM-003, a proprietary long-acting glucagon-like peptide-2 receptor agonist for prevention of acute graft versus host disease; NM-136, a humanized monoclonal antibody for targeted obesity disorders; and NM-004, a double-cleaved mesalamine with an immunomodulator for rare and/or orphan indications. The company is based in Raleigh, North Carolina.

      Frequently Asked Questions

      icon

      What is the current 9 Meters Biopharma, Inc. (NMTR) stock price?

      9 Meters Biopharma, Inc. (NASDAQ: NMTR) stock price is $0.66 in the last trading session. During the trading session, NMTR stock reached the peak price of $0.80 while $0.75 was the lowest point it dropped to. The percentage change in NMTR stock occurred in the recent session was -18.54% while the dollar amount for the price change in NMTR stock was -$0.15.

      icon

      NMTR's industry and sector of operation?

      The NASDAQ listed NMTR is part of Biotechnology industry that operates in the broader Healthcare sector. 9 Meters Biopharma, Inc. , a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders.

      icon

      Who are the executives of NMTR?

      Mr. John Temperato
      Pres, Chief Executive Officer & Director
      Mr. Sireesh Appajosyula Pharm.D.
      Senior Vice President of Corporation Devel. & Operations
      Dr. Nir Barak M.D.
      Senior Vice President of Scientific Affairs
      Mr. Albert J. Medwar M.B.A., MBA
      Senior Vice President of Investor Relations & Corporation Communications

      icon

      How NMTR did perform over past 52-week?

      NMTR's closing price is 0.01% higher than its 52-week low of $0.575 where as its distance from 52-week high of $13.2 is -0.95%.

      icon

      How many employees does NMTR have?

      Number of NMTR employees currently stands at 10.00. NMTR operates from 8480 Honeycutt Road</br>Raleigh, NC 27615</br>US.

      icon

      Link for NMTR official website?

      Official Website of NMTR is: https://www.9meters.com

      icon

      How do I contact NMTR?

      NMTR could be contacted at phone #919 275 1933 and can also be accessed through its website. NMTR operates from 8480 Honeycutt Road</br>Raleigh, NC 27615</br>US.

      icon

      How many shares of NMTR are traded daily?

      NMTR stock volume for the day was 355314.00 shares. The average number of NMTR shares traded daily for last 3 months was 77 Thousands.

      icon

      What is the market cap of NMTR currently?

      The market value of NMTR currently stands at $10 Million with its latest stock price at $0.66 and 13 Million of its shares outstanding.